Prolonged retention of vaccinia virus complement control protein following IP injection: implications in blocking xenorejection

This publication has 13 references indexed in Scilit:

• Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation
  Transplant Immunology, 2003
• Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding
  Transplantation Proceedings, 2002
• Potential Intervention by Vaccinia Virus Complement Control Protein of the Signals Contributing to the Progression of Central Nervous System Injury to Alzheimer's Disease
  Annals of the New York Academy of Sciences, 2002
• Vaccinia Virus Complement Control Protein Enhances Functional Recovery after Traumatic Brain Injury
  Journal of Neurotrauma, 2002
• Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system
  Journal of Neuroimmunology, 2000
• Pro-inflammatory complement activation by the Aβ peptide of Alzheimer’s disease is biologically significant and can be blocked by vaccinia virus complement control protein
  Neurobiology of Aging, 1998
• Regulation of Complement Activity by Vaccinia Virus Complement-Control Protein
  The Journal of Infectious Diseases, 1992
• Inhibition of the Complement Cascade by the Major Secretory Protein of Vaccinia Virus
  Science, 1990
• THE MECHANISM OF DISCORDANT XENOGRAFT REJECTION
  Transplantation, 1988
• Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
  Nature, 1988